The leukemic presentation of mantle-cell lymphoma: Disease features and prognostic factors in 58 patients

Leukemia and Lymphoma

Volumn 45, Issue 10, 2004, Pages 2007-2015

  Matutes, Estella ^a   Parry Jones, N ^a   Brito Babapulle, V ^a   Wotherspoon, A ^a   Morilla, R ^a   Atkinson, S ^a   Elnenaei, M O ^a   Jain, P ^a   Giustolisi, G M ^a   A'Hern, R P ^a   Catovsky, D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Clinical features; Leukemia; Mantle cell lymphoma; Prognostic factors; Splenectomy

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BIOLOGICAL MARKER; CD23 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; CHLORAMBUCIL; CYCLIN D1; FLUDARABINE; PENTOSTATIN;

ADULT; ANEMIA; ANTIGEN EXPRESSION; ARTICLE; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHADENOPATHY; LYMPHOCYTE COUNT; LYMPHOCYTOMA; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MORPHOLOGY; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SPLENECTOMY; SPLENOMEGALY; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CYCLIN D1; CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SPLENECTOMY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4544332737     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190410001723331     Document Type: Article

References (45)

1. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group". Blood, 84, 1361-1392.
2. Raffeld, M. and Jaffe, E.S. (1991) "bcl-1, t(11;14), and mantle cell-derived lymphomas". Blood, 78, 259-263.
3. Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W. (eds) (2001) World health organisation classification of tumours. Tumours of haemopoietic and lymphoid tissues., 1st edn. IARC Press: Lyon.
4. Argatoff, L.H., Connors, J.M., Klasa, R.J., Horsman, D.E. and Gascoyne, R.D. (1997) "Mantle cell lymphoma: a clinicopathologic study of 80 cases". Blood, 89, 2067-2078.
5. Barista, I., Romaguera, J.E. and Cabanillas, F. (2001) "Mantle-cell lymphoma". Lancet Oncology, 2, 141-148.
6. Bernard, M., Gressin, R., Lefrere, F., Drenou, B., Branger, B., Caulet-Maugendre, S., et al. (2001) "Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype". Leukemia, 15, 1785-1791.
7. Duggan, M.J., Weisenburger, D.D., Ye, Y.L., Bast, M.A., Pierson, J.L., Linder, J., et al. (1990) "Mantle zone lymphoma. A clinicopathologic study of 22 cases". Cancer, 66, 522-529.
8. Cuneo, A., Bigoni, R., Rigolin, G.M., Roberti, M.G., Bardi, A., Piva, N., et al. (1999) "Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features" . Blood, 93, 1372-1380.
9. Greiner, T.C., Moynihan, M.J., Chan, W.C., Lytle, D.M., Pedersen, A., Anderson, J.R., et al. (1996) "p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis". Blood, 87, 4302-4310.
10. Majlis, A., Pugh, W.C., Rodriguez, M.A., Benedict, W.F. and Cabanillas, F. (1997) "Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants". Journal of Clinical Oncology, 15, 1664-1671.
11. Norton, A.J., Matthews, J., Pappa, V., Shamash, J., Love, S., Rohatiner, A.Z., et al. (1995) "Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period". Annals of Oncology, 6, 249-256.
12. Pittaluga, S., Verhoef, G., Criel, A., Maes, A., Nuyts, J., Boogaerts, M., et al. (1996) "Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma". Leukemia Lymphoma, 21, 115-125.
13. Samaha, H., Dumontet, C., Ketterer, N., Moullet, I., Thieblemont, C., Bouafia, F., et al. (1998) "Mantle cell lymphoma: a retrospective study of 121 cases". Leukemia, 12, 1281-1287.
14. Velders, G.A., Kluin-Nelemans, J.C., De Boer, C.J., Hermans, J., Noordijk, E.M., Schuuring, E., et al. (1996) "Mantle-cell lymphoma: a population-based clinical study". Journal of Clinical Oncology, 14, 1269-1274.
15. Yatabe, Y., Nakamura, S., Seto, M., Kuroda, H., Kagami, Y., Suzuki, R., et al. (1996) "Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity". American Journal of Surgical Pathology, 20, 1110-1122.
16. Yatabe, Y., Suzuki, R., Tobinai, K., Matsuno, Y., Ichinohasama, R., Okamoto, M., et al. (2000) "Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma". Blood, 95, 2253-2261.
17. Zoldan, M.C., Inghirami, G., Masuda, Y., Vandekerckhove, F., Raphael, B., Amorosi, E., et al. (1996) "Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome". British Journal of Haematology, 93, 475-486.
18. Bosch, F., Lopez-Guillermo, A., Campo, E., Ribera, J.M., Conde, E., Piris, M.A., et al. (1998) "Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors". Cancer, 82, 567-575.
19. Cohen, P.L., Kurtin, P.J., Donovan, K.A. and Hanson, C.A. (1998) "Bone marrow and peripheral blood involvement in mantle cell lymphoma". British Journal of Haematology, 101, 302-310.
20. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M.A., Villamor, N., et al. (1994) "PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma". Blood, 84, 2726-2732.
21. Bigoni, R., Negrini, M., Veronese, M.L., Cuneo, A., Castoldi, G.L. and Croce, C.M. (1996) "Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization". Oncogene, 13, 797-802.
22. Elnenaei, M.O., Jadayel, D.M., Matutes, E., Morilla, R., Owusu-Ankomah, K., Atkinson, S., et al. (2001) "Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies". Leukemia Research, 25, 115-123.
23. Matutes, E., Carrara, P., Coignet, L., Brito-Babapulle, V., Villamor, N., Wotherspoon, A., et al. (1999) "FISH analysis for BCL-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemias". Leukemia, 13, 1721-1726.
24. Ott, M.M., Helbing, A., Ott, G., Bartek, J., Fischer, L., Durr, A., et al. (1996) "bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma". Journal of Pathology, 179, 238-242.
25. Vaandrager, J.W., Schuuring, E., Zwikstra, E., de Boer, C.J., Kleiverda, K.K., van Kricken, J.H., et al. (1996) "Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization". Blood, 88, 1177-1182.
26. Onciu, M., Schlette, E., Medeiros, L.J., Abruzzo, L.V., Keating, M. and Lai, R. (2001) "Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities". American Journal of Clinical Pathology, 116, 886-892.
27. Hernandez, L., Fest, T., Cazorla, M., Teruya-Feldstein, J., Bosch, F., Peinado, M.A., et al. (1996) "p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas". Blood, 87, 3351-3359.
28. Ott, G., Kalla, J., Ott, M.M., Schryen, B., Katzenberger, T., Muller, J.G., et al. (1997) "Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones". Blood, 89, 1421-1429.
29. Pinyol, M., Hernandez, L., Cazorla, M., Balbin, M., Jares, P., Fernandez, P.L., et al. (1997) "Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas". Blood, 89, 272-280.
30. Wong, K.F., Chan, J.K., So, J.C. and Yu, P.H. (1999) "Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders". Cancer, 86, 850-857.
31. Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T.H. and Catovsky, D. (1994) "The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL". Leukemia, 8, 1640-1645.
32. Moreau, E.J., Matutes, E., A'Hern, R.P., Morilla, A.M., Morilla, R.M., Owusu-Ankomah, K.A., et al. (1997) "Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)". American Journal of Clinical Pathology, 108, 378-382.
33. Jain, P., Giustolisi, G.M., Atkinson, S., Elnenaei, M.O., Morilla, R., Owusu-Ankomah, K., et al. (2002) "Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry". Journal of Clinical Pathology, 55, 940-945.
34. De Angeli, C., Gandini, D., Cuneo, A., Moretti, S., Bigoni, R., Roberti, M.G., et al. (2000) "BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32 ". Haematologica, 85, 913-921.
35. De Oliveira, M.S., Jaffe, E.S. and Catovsky, D. (1989) "Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases". Journal of Clinical Pathology, 42, 962-972.
36. Yoong, Y., Kurtin, P.J., Allmer, C., Geyer, S., Habermann, T.M., Nagorney, D.M., et al. (2001) "Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphoma". Leukemia Lymphoma, 42, 1235-1241.
37. Ruchlemer, R., Wotherspoon, A.C., Thompson, J.N., Swansbury, J.G., Matutes, E. and Catovsky, D. (2002) "Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia". British Journal of Haematology, 118, 952-958.
38. Decaudin, D., Bosq, J., Tertian, G., Nedellec, G., Bennaceur, A., Venuat, A.M., et al. (1998) "Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas". Journal of Clinical Oncology, 16, 579-583.
39. Foran, J.M., Rohatiner, A.Z., Coiffier, B., Barbui, T., Johnson, S.A., Hiddemann, W., et al. (1999) "Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma". Journal of Clinical Oncology, 17, 546-543.
40. Zinzani, P.L., Magagnoli, M., Moretti, L., Battista, R., Ronconi, F., De Renzo, A., et al. (1999) "Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients". Haematologica, 84, 1002-1006.
41. Cohen, B.J., Moskowitz, C., Straus, D., Noy, A., Hedrick, E. and Zelenetz, A. (2001) "Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma". Leukemia Lymphoma, 42, 1015-1022.
42. Rummel, M.J., Chow, K.U., Karakas, T., Jager, E., Mezger, J., von Grunhagen, U., et al. (2002) "Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma". European Journal of Cancer, 38, 1739-1746.
43. Hiddemann, W., Dreyling, M. and Unterhalt, M. (2003) "Rituximab plus chemotherapy in follicular and mantle cell lymphomas". Seminars in Oncology, 30, 16-20.
44. Solenthaler, M., Matutes, E., Brito-Babapulle, V., Morilla, R. and Catovsky, D. (2002) "p53 and mdm2 in mantle cell lymphoma in leukemic phase". Haematologica, 87, 1141-1150.
45. Orchard, J., Garand, R., Davis, Z., Babbage, G., Sahota, S., Matutes, E., et al. (2003) "A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease". Blood, 101, 4975-4981.